Drug · DIN 02342243
VTRS-ELETRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 16, 2026; first marketed October 11, 2012.
- Drug Identification Number (DIN)
- 02342243
- Company (DIN owner)
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Eletriptan N02CC06
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELETRIPTAN (ELETRIPTAN HYDROBROMIDE) | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 16, 2026: NOC 37926Supplement to a New Drug Submission (SNDS) · Change in product name
- December 5, 2023: NOC 32293New Drug Submission (NDS) · Administrative: Change in Product Ownership. Administrative: Licensing Agreement Between Two Manufacturers
- May 13, 2020: NOC 23590New Drug Submission (NDS) · Change in product ownership
- January 26, 2010: NOC 10955New Drug Submission (NDS) · New manufacturer and product name
Other DINs named VTRS-ELETRIPTAN
- DIN 02342235 · Marketed